Clinigence
Qualified Clinical Data Registry
Clinigence was approved by the Center for Medicare and Medicaid Services (CMS) as a Qualified Clinical Data Registry (QCDR).
Clinigence provides QCDR reporting for the measures listed below and for a wide variety of standard MIPS/MACRA measures. Our quality reporting technology, professional services and educational resources provides the needed support for MACRA readiness for specialty groups.
Oncology
Measure Name: Cancer Patients – Survivorship Care Plan
Measure ID: CLLC3
Description: Percentage of patients with an encounter for follow-up examination after completed treatment for malignant neoplsm who have a survivorship care plan documented on the same date
Rational: The Institute of Medicine identified the need for a survivorship care plan as a key factor to help cancer patients transition to long term surveillance care, avoid unnecessary services, and seek appropriate rehabilitative care and emotional support.
Denominator: All patients with an encounter for follow-up examination after completed treatment for malignant neoplasm during the measurement period
Numerator: Patients with a documented survivorship care plan not later than the most recent encounter for follow-up examination after completed treatment for malignant neoplasm.
Denominator Exceptions & Exclusions: N/A
Podiatry
Measure Name: Foot Bone Infection Diagnosis Without MRI
Measure ID: CLLC4
Description: Percentage of patients with a diagnosis of bone infection (osteomyelitis) in the foot who had an MRI of the foot.
Rational: When the diagnosis of osteomyelitis can be reliably established by clinical means and/or serial plain film radiographs, MRI is generally unnecessary. Furthermore, MRI is particularly poor at differentiating osteomyelitis from benign postoperative marrow edema and from marrow edema due to Charcot arthropathy. Use of MRI in these instances can lead to a false positive interpretation and potentially harmful overtreatment.
Denominator: Patients with a diagnosis of osteomyelitis in the foot
Numerator: Patients who had an MRI of the foot during the 30 days prior to the diagnosis of osteomyelitis
Denominator Exceptions & Exclusions: N/A
Orthopaedics – Neurology
Measure Name: Back Pain: Use of EMG & CNS
Measure ID: CLLC1
Description: Percentage of patients with a diagnosis of axial lumbar, thoracic or cervical spine pain who had an electromyography (EMG) or nerve conduction study (NCS) within 30 days of the diagnosis.
Rational: Electromyography and nerve conduction studies are measures of nerve and muscle function. They may be indicated when there is concern for a neurologic injury or disorder, such as the presence of leg or arm pain, numbness or weakness associated with compression of a spinal nerve. As spinal nerve injury is not a cause of neck, mid back or low back pain, EMG/NCS have not been found to be helpful in diagnosing the underlying causes of axial lumbar, thoracic and cervical spine pain.
Denominator: All Patients with a diagnosis of axial lumbar, thoracic or cervical spine pain during the measurement period
Numerator: Patients who had an electromyography (EMG) or nerve conduction study (NCS) within 30 days of the diagnosis.
Denominator Exceptions & Exclusions: N/A
Orthopaedics – Podiatry
Measure Name: Morton’s Neuroma – Avoidance of Alcohol Injections
Measure ID: CLLC2
Description: Percentage of patients with a diagnosis of Morton’s neuroma who received alcohol injections
Rational: Percentage of patients with a diagnosis of Morton’s neuroma who received alcohol injections
Denominator: All patients with a diagnosis of Morton’s neuroma during the measurement period
Numerator: Patients who received alcohol injections following the diagnosis of Morton’s neuroma
Denominator Exceptions & Exclusions: N/A